S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL
Authors: M Heeney, D Rees, M de Montalembert, I Odame, C Brown, Y Wali, T Nguyen, D Lam, N Pfender, J Kanter